← Leaderboards
Scott W Walsh
Virginia Commonwealth University
$7,235,742
Attributed
$9,350,209
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$9,350,209 · 4
By mechanism
R01$4,319,261 · 2
U01$4,228,935 · 1
P60$802,013 · 1
Top collaborators
- Charles E Chalfant1 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Sarah Spiegel$20,919,449
- Daniel H Conrad$9,937,904
- Carole A Oskeritzian$3,176,471
- Yan Zhang$14,997,952
- Bin Gao$700,617
Others in their field
Top investigators on “Pregnancy”
- Chanza Baytop · Westat, Inc.$271,217,917
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$158,777,707
- Barbara Driver · Westat, Inc.$117,058,181
- Myron S Cohen · Family Health International$101,800,876
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
Research focus
PregnancyWomanGenesFetalEpigenetic ProcessNeutrophilPre-EclampsiaFunctional DisorderInflammatoryNeutrophil InfiltrationNuclearMediatingBlood VesselsInhibitor/AntagonistInflammationTissuesNeutrophil ActivationThromboxanesPatternInflammatory ResponsePhosphotransferasesMethylationDna MethylationMorbidity - Disease Rate
Grant awards (20)
Pregnancy Specific Protease Activation of PAR-1 and TET2 in Preeclampsia-Implications for Therapy$315,701
R01 · FY2021 · HD · contact PI
Pregnancy Specific Protease Activation of PAR-1 and TET2 in Preeclampsia-Implications for Therapy$322,144
R01 · FY2020 · HD · contact PI
Pregnancy Specific Protease Activation of PAR-1 and TET2 in Preeclampsia-Implications for Therapy$322,144
R01 · FY2019 · HD · contact PI
Pregnancy Specific Protease Activation of PAR-1 and TET2 in Preeclampsia-Implications for Therapy$321,625
R01 · FY2018 · HD · contact PI
Pregnancy Specific Protease Activation of PAR-1 and TET2 in Preeclampsia-Implications for Therapy$321,625
R01 · FY2017 · HD · contact PI
Research Core$180,227
P60 · FY2016 · MD · contact PI
The utilization of photonics technology to rapidly detect bioactive lipids associated with preeclampsia development$4,228,935
U01 · FY2015 · HD · contact PI
Research Core$180,228
P60 · FY2015 · MD · contact PI
Research Core$180,228
P60 · FY2014 · MD · contact PI
Oxidant Stress Mechanisms in Preeclampsia$345,180
R01 · FY2013 · HL · contact PI
Research Core$81,102
P60 · FY2013 · MD · contact PI
Oxidant Stress Mechanisms in Preeclampsia$362,870
R01 · FY2012 · HL · contact PI
Research Core$180,228
P60 · FY2012 · MD · contact PI
Oxidant Stress Mechanisms in Preeclampsia$366,813
R01 · FY2011 · HL · contact PI
Oxidant Stress Mechanisms in Preeclampsia$367,080
R01 · FY2010 · HL · contact PI
Oxidant Stress Mechanisms in Preeclampsia$245,016
R01 · FY2007 · HL · contact PI
Oxidant Stress Mechanisms in Preeclampsia$252,488
R01 · FY2006 · HL · contact PI
Oxidant Stress Mechanisms in Preeclampsia$258,715
R01 · FY2005 · HL
Oxidant Stress Mechanisms in Preeclampsia$258,860
R01 · FY2004 · HL
Oxidant Stress Mechanisms in Preeclampsia$259,000
R01 · FY2003 · HL